Key result
Troglitazone administration for 6 months decreased blood pressure and left ventricular mass, and improved insulin sensitivity and myocardial norepinephrine turnover in hypertensive patients.
Why the study?
Does troglitazone improve cardiovascular variables and cardiac sympathetic neuronal function in essential hypertensives with insulin resistance and left ventricular hypertrophy?
Population
Patients with high blood pressure, reduced insulin sensitivity, and echocardiographic evidence of left…
Comparison
Troglitazone combined with existing… vs None
Design
Editorial
Follow-up
6 months
Authors
Loading...
This editorial highlights that while troglitazone improves cardiovascular and sympathetic parameters in hypertensive patients with insulin resistance, limitations in study design and imaging techniques leave the exact mechanisms of insulin-sympathetic interactions unresolved.
Does troglitazone improve cardiovascular variables and cardiac sympathetic neuronal function in essential hypertensives with insulin resistance and left ventricular hypertrophy?
This editorial highlights that while troglitazone improves cardiovascular and sympathetic parameters in hypertensive patients with insulin resistance, limitations in study design and imaging techniques leave the exact mechanisms of insulin-sympathetic interactions unresolved.
Guıdo Grassı (2004) conducted an editorial in Essential hypertension. Troglitazone was evaluated on Blood pressure, left ventricular mass, insulin sensitivity, and myocardial norepinephrine turnover. Troglitazone administration for 6 months decreased blood pressure and left ventricular mass, and improved insulin sensitivity and myocardial norepinephrine turnover in hypertensive patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: